Liraglutide achieves HbA1c targets more often than sitagliptin or exenatide when added to metformin in patients with Type 2 diabetes and a baseline HbA1c < 8.0% Article

Web of Science: 000316263400175
Industry Collaboration International Collaboration

Cited authors

  • Davies, M.; King, A. B.; Montanya, E.; Pratley, R. E.; Blonde, L.; Svendsen, C. B.; Donsmark, M.; Sesti, G.

Authors

Publication date

  • 2013

Published in

Category

International Standard Serial Number (ISSN)

  • 0742-3071

Start page

  • 57

End page

  • 57

Volume

  • 30